CGC vs. TLRY, CRON, USNA, MNMD, BTMD, ACB, CDXC, MDWD, FTLF, and NAII
Should you be buying Canopy Growth stock or one of its competitors? The main competitors of Canopy Growth include Tilray (TLRY), Cronos Group (CRON), USANA Health Sciences (USNA), Mind Medicine (MindMed) (MNMD), biote (BTMD), Aurora Cannabis (ACB), ChromaDex (CDXC), MediWound (MDWD), FitLife Brands (FTLF), and Natural Alternatives International (NAII). These companies are all part of the "medicinals & botanicals" industry.
Canopy Growth (NASDAQ:CGC) and Tilray (NASDAQ:TLRY) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations, community ranking and media sentiment.
3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 9.4% of Tilray shares are held by institutional investors. 0.4% of Canopy Growth shares are held by company insiders. Comparatively, 0.7% of Tilray shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Tilray has higher revenue and earnings than Canopy Growth. Tilray is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.
Canopy Growth currently has a consensus target price of $4.87, suggesting a potential downside of 42.95%. Tilray has a consensus target price of $2.71, suggesting a potential upside of 50.46%. Given Tilray's stronger consensus rating and higher possible upside, analysts clearly believe Tilray is more favorable than Canopy Growth.
Tilray has a net margin of -43.98% compared to Canopy Growth's net margin of -185.77%. Tilray's return on equity of -2.68% beat Canopy Growth's return on equity.
Tilray received 427 more outperform votes than Canopy Growth when rated by MarketBeat users. Likewise, 59.28% of users gave Tilray an outperform vote while only 19.80% of users gave Canopy Growth an outperform vote.
In the previous week, Canopy Growth had 2 more articles in the media than Tilray. MarketBeat recorded 14 mentions for Canopy Growth and 12 mentions for Tilray. Canopy Growth's average media sentiment score of 0.93 beat Tilray's score of 0.37 indicating that Canopy Growth is being referred to more favorably in the media.
Canopy Growth has a beta of 1.1, meaning that its stock price is 10% more volatile than the S&P 500. Comparatively, Tilray has a beta of 2.36, meaning that its stock price is 136% more volatile than the S&P 500.
Summary
Tilray beats Canopy Growth on 14 of the 18 factors compared between the two stocks.
Get Canopy Growth News Delivered to You Automatically
Sign up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Canopy Growth Competitors List
Related Companies and Tools
